According to Evolent Health's latest financial reports the company has $0.19 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.19 B | 2.46% |
2022-12-31 | $0.18 B | -29.32% |
2021-12-31 | $0.26 B | -16.53% |
2020-12-31 | $0.31 B | 210.27% |
2019-12-31 | $0.10 B | -54.97% |
2018-12-31 | $0.22 B | -4.24% |
2017-12-31 | $0.23 B | 33.27% |
2016-12-31 | $0.17 B | 15.29% |
2015-12-31 | $0.15 B | |
2014-12-31 | $N/A | -100% |
2013-12-31 | $67.89 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
National Healthcare
NHC | $0.22 B | 15.97% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $1.04 B | 444.33% | ๐ญ๐ฐ Hong Kong |
Graham Holdings GHC | $0.86 B | 349.59% | ๐บ๐ธ USA |
CryoLife CRY | N/A | N/A | ๐บ๐ธ USA |